Skip to main content

Integrated Care Boosts Smoking Cessation When Undergoing Lung Cancer Screening

Medically reviewed by Carmen Pope, BPharm. Last updated on Jan 19, 2025.

By Lori Solomon HealthDay Reporter

FRIDAY, Jan. 17, 2025 -- Integrated care (IC) involving medication and intensive counseling provides the best opportunity for smoking cessation in the context of lung cancer screening (LCS), according to a study published online Jan. 13 in JAMA Internal Medicine.

Paul M. Cinciripini, Ph.D., from the University of Texas MD Anderson Cancer Center in Houston, and colleagues evaluated the efficacy of three tobacco treatment strategies in the LCS setting. The analysis included 630 participants randomly assigned to quitline (QL; including 12-week nicotine replacement therapy [NRT]), QL plus 12-week NRT or pharmacotherapy (QL+), or IC (12-week NRT or prescription pharmacotherapy and counseling).

The researchers found that at three months, 25.2 percent in QL, 27.1 percent in QL+, and 37.1 percent in IC reported abstinence. IC performed better than both QL (odds ratio, 1.75) and QL+ (odds ratio, 1.58). IC maintained the highest rate of abstinence at six months, with 32.4 percent, followed by QL+ at 27.6 percent, and QL at 20.5 percent (IC versus QL: odds ratio, 1.86). IC showed a higher probability of positive absolute risk differences (ARDs) in abstinence at three months versus QL (ARD, 0.12) in the Bayesian analysis with 99 percent probability of positive ARD and versus QL+ (ARD, 0.10) with 98 percent probability of positive ARD. At six months, this advantage was maintained with ARDs of 0.12 versus QL (probability of positive ARD, 99 percent) and 0.05 versus QL+ (probability of positive ARD, 86 percent).

"The superior performance of the IC model underscores the value of integrated, comprehensive approaches to smoking cessation in the LCS setting, which could be an important consideration when referring patients for screening," the authors write.

Several authors disclosed ties to relevant organizations.

Abstract/Full Text (subscription or payment may be required)

Editorial (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted January 2025

Read this next

Pod-Style E-Cigarettes May Have Higher Abuse Liability Than Nicotine Gum

THURSDAY, May 29, 2025 -- Modern pod-style electronic cigarette (ECIG) devices may have a higher abuse liability than nicotine gum in individuals with no history of cigarette...

ASCO: Maintenance Lurbinectedin + Atezolizumab Enhances Survival in Lung Cancer

TUESDAY, May 27, 2025 -- Maintenance therapy with lurbinectedin (lurbi) and atezolizumab (atezo) helps some patients with extensive-stage small cell lung cancer (ES-SCLC)...

Standardized Branding of Disposable Vaping Devices Reduces Young People's Interest

FRIDAY, May 23, 2025 -- Standardizing the color and branding of disposable vaping devices reduces young people’s interest in trying them, according to a study published...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.